vs
Side-by-side financial comparison of Local Bounti Corporation (LOCL) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $12.5M, roughly 1.0× Local Bounti Corporation). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -69.8%, a 320.5% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 23.7%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 21.9%).
Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.
LOCL vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.5M | $12.6M |
| Net Profit | $-8.7M | $31.5M |
| Gross Margin | 12.2% | — |
| Operating Margin | -106.1% | — |
| Net Margin | -69.8% | 250.7% |
| Revenue YoY | 23.7% | 24080.8% |
| Net Profit YoY | 76.0% | 250.9% |
| EPS (diluted) | $1.52 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.5M | $12.6M | ||
| Q3 25 | $12.2M | $0 | ||
| Q2 25 | $12.1M | $0 | ||
| Q1 25 | $11.6M | $12.0K | ||
| Q4 24 | $10.1M | $52.0K | ||
| Q3 24 | $10.2M | $65.0K | ||
| Q2 24 | $9.4M | $114.0K | ||
| Q1 24 | $8.4M | $140.0K |
| Q4 25 | $-8.7M | $31.5M | ||
| Q3 25 | $-26.4M | $-7.4M | ||
| Q2 25 | $-21.6M | $-1.7M | ||
| Q1 25 | $-37.7M | $-13.9M | ||
| Q4 24 | $-36.3M | — | ||
| Q3 24 | $-34.3M | $-17.1M | ||
| Q2 24 | $-25.3M | $-17.9M | ||
| Q1 24 | $-24.1M | $-12.7M |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | 12.2% | — | ||
| Q1 25 | 12.6% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 9.4% | — |
| Q4 25 | -106.1% | — | ||
| Q3 25 | -149.4% | — | ||
| Q2 25 | -127.7% | — | ||
| Q1 25 | -135.6% | -122758.3% | ||
| Q4 24 | -166.6% | — | ||
| Q3 24 | -176.0% | -28604.6% | ||
| Q2 24 | -146.8% | -16720.2% | ||
| Q1 24 | -122.9% | -9987.1% |
| Q4 25 | -69.8% | 250.7% | ||
| Q3 25 | -216.6% | — | ||
| Q2 25 | -178.3% | — | ||
| Q1 25 | -324.6% | -115550.0% | ||
| Q4 24 | -360.1% | — | ||
| Q3 24 | -335.2% | -26380.0% | ||
| Q2 24 | -267.6% | -15668.4% | ||
| Q1 24 | -286.9% | -9049.3% |
| Q4 25 | $1.52 | $0.56 | ||
| Q3 25 | $-1.18 | $-0.13 | ||
| Q2 25 | $-1.63 | $-0.03 | ||
| Q1 25 | $-4.32 | $-0.25 | ||
| Q4 24 | $-4.24 | — | ||
| Q3 24 | $-4.01 | $-0.32 | ||
| Q2 24 | $-3.00 | $-0.33 | ||
| Q1 24 | $-2.89 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $40.3M |
| Total DebtLower is stronger | $483.1M | — |
| Stockholders' EquityBook value | $-166.2M | $59.0M |
| Total Assets | $410.5M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.2M | $40.3M | ||
| Q3 25 | $6.2M | $48.6M | ||
| Q2 25 | $5.3M | $31.2M | ||
| Q1 25 | $18.0M | $48.9M | ||
| Q4 24 | $937.0K | $52.9M | ||
| Q3 24 | $317.0K | $76.3M | ||
| Q2 24 | $9.7M | $63.5M | ||
| Q1 24 | $8.2M | $82.3M |
| Q4 25 | $483.1M | — | ||
| Q3 25 | $484.9M | — | ||
| Q2 25 | $478.3M | — | ||
| Q1 25 | $480.0M | — | ||
| Q4 24 | $436.8M | — | ||
| Q3 24 | $398.4M | — | ||
| Q2 24 | $374.0M | — | ||
| Q1 24 | $329.8M | — |
| Q4 25 | $-166.2M | $59.0M | ||
| Q3 25 | $-158.1M | $26.5M | ||
| Q2 25 | $-132.7M | $32.8M | ||
| Q1 25 | $-134.5M | $33.8M | ||
| Q4 24 | $-100.5M | $46.1M | ||
| Q3 24 | $-65.6M | $65.5M | ||
| Q2 24 | $-32.8M | $80.5M | ||
| Q1 24 | $-9.4M | $96.2M |
| Q4 25 | $410.5M | $68.9M | ||
| Q3 25 | $417.8M | $54.2M | ||
| Q2 25 | $426.8M | $62.1M | ||
| Q1 25 | $447.2M | $77.7M | ||
| Q4 24 | $428.0M | $110.5M | ||
| Q3 24 | $430.8M | $135.2M | ||
| Q2 24 | $438.1M | $149.9M | ||
| Q1 24 | $413.4M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.1M | $-8.4M |
| Free Cash FlowOCF − Capex | $-3.6M | — |
| FCF MarginFCF / Revenue | -29.1% | — |
| Capex IntensityCapex / Revenue | 3.9% | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-42.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.1M | $-8.4M | ||
| Q3 25 | $-8.9M | $17.4M | ||
| Q2 25 | $-8.7M | $-17.7M | ||
| Q1 25 | $-9.6M | $-4.0M | ||
| Q4 24 | $1.2M | $-23.4M | ||
| Q3 24 | $-17.2M | $12.8M | ||
| Q2 24 | $-4.0M | $-18.7M | ||
| Q1 24 | $-7.1M | $5.9M |
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $-10.1M | — | ||
| Q2 25 | $-14.6M | — | ||
| Q1 25 | $-14.5M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-30.0M | — | ||
| Q2 24 | $-28.8M | — | ||
| Q1 24 | $-42.1M | — |
| Q4 25 | -29.1% | — | ||
| Q3 25 | -82.8% | — | ||
| Q2 25 | -121.0% | — | ||
| Q1 25 | -125.1% | — | ||
| Q4 24 | -85.3% | — | ||
| Q3 24 | -293.1% | — | ||
| Q2 24 | -305.4% | — | ||
| Q1 24 | -501.8% | — |
| Q4 25 | 3.9% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 48.9% | — | ||
| Q1 25 | 42.8% | — | ||
| Q4 24 | 97.6% | — | ||
| Q3 24 | 125.0% | — | ||
| Q2 24 | 263.0% | — | ||
| Q1 24 | 417.3% | — |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
